BioSpace15d
Atrial Flutter Market Projected to Grow at 4.56% CAGR during 2025-2035, Impelled by Rising Prevalence of Cardiovascular Diseases
Atrial Flutter Market Outlook 2025-2035: The atrial flutter market is expected to exhibit a CAGR of 4.56% during 2025-2035. The atrial flutter market is growing as cardiovascular diseases become more ...
The New England Journal of Medicine17d
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
The safety of abelacimab as compared with a direct oral anticoagulant in patients with atrial fibrillation is ... adjustment for multiple testing. No imputation was performed for missing data ...
Harvard Business Review25d
How to Get Better at Saying No
But when individuals learn to say no more often, it can have huge benefits for their careers and organizations, says Dr. Sunita Sah. A psychologist and professor at Cornell’s SC Johnson College ...
MassDevice25d
Alleviant Medical raises $90M for no-implant atrial shunt
This no-implant atrial shunt could offer an effective treatment for heart failure. [Image courtesy of Alleviant Medical] Alleviant Medical announced today that it raised $90 million to fund the ...
Medscape28d
Criteria for Patient Selection in Cardiac Resynchronization Therapy
In the COMPANION trial, 1520 patients with heart failure in functional status/NYHA class III/IV, QRS width greater than ... in the German guideline IIb C; Atrial fibrillation, EF less than or ...